antibody

Human EGFR F(ab')2 (Research Grade Depatuxizumab Biosimilar) Antibody

MAB9583-100

100 ug (also 25 ug)

479 USD

monoclonal

human

nonconjugated

Hu210

MAB9583-100

Human EGFR F(ab')2 (Research Grade Depatuxizumab Biosimilar) Antibody

100 ug (also 25 ug)

The Human EGFR F(ab')2 (Research Grade Depatuxizumab Biosimilar) Antibody from R&D Systems is a human monoclonal antibody to EGFR. This antibody reacts with human. The Human EGFR F(ab')2 (Research Grade Depatuxizumab Biosimilar) Antibody has been validated for the following applications: ELISA.

EGFR

Primary Antibodies

Lyophilized from a 0.2 ╡m filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 ╡m filtered solution in PBS.

Monoclonal

Hu210

Unconjugated

Human

Human EGFR F(ab')2

IgG1

Protein A or G purified from cell culture supernatant

Human

ELISA

Recombinant Monoclonal Antibody For Research Use Only

479 USD

Recombinant Monoclonal Antibody For Research Use Only

avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, EC 2.7.10, EC 2.7.10.1, EGF R, epidermal growth factor receptor, epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b)oncogene homolog), ErbB, ErbB1, ERBB1PIG61, HER1, HER-1, mENA, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 6 months, -20 to -70 ░C under sterile conditions after reconstitution.